Instituto de Investigaciones Clínicas (IIC) - Rosario
Sabemos priorizar al paciente, somos especialistas en investigaciones clínicas. Contamos con más de 20 años de trayectoria en el área médica científica, con la experiencia de nuestros profesionales y equipamientos de última tecnologíaParaguay 160, S2000CVD Rosario, Santa Fe, Argentina
Websitehttps://iic-rosario.com.ar/
Select an option
I am a doctor
I am a sponsor
Specializations
Cardiología
Nefrología
Obesidad
Diabetes
Reumatología
Dermatología
Alergia, Inmunología
Neumonología
Neurología
Psiquiatría
Clínica Médica
Enfermedades Autoinmunes
Oftalmología
Oncología
Our team
Authorities
Directora Médica - Investigadora - Cardiología, Diabetes y Obesidad Carolina Chacón
Medical staff
Investigadora - Alergia e InfectologíaMarcela Cariñani
Investigadora - CardiologíaJorgelina Sala
Investigador - NeurologíaMauricio Bosch
Investigadora - CardiologíaMariela Rasmussen
Investigador - NefrologíaGustavo Lavenia
Investigadora - DermatologíaAgustina Galvan
Investigadora - ReumatologíaMarina Carcamo
Investigadora - CardiologíaVirginia Cavazza
Investigadora - Médica ClínicaMariana Castro
Investigador - Clinica Médica - DiabetologíaMaximilano Sicer
Investigadora - CardiologíaLiza Bergues
Investigadora - Medica Clínica - Enfermedades AutoinmunesMariana Lagrutta
Legal and Administrative staff
Study CoordinatorValentina Amaya
Study CoordinatorStefania Scolari
General Site CoordinatorCamila Eguiluz
Study CoordinatorFernando Oliva
Study CoordinatorSabrina Decima
Study CoordinatorSofia Chiesa
Open studies
Diabetes
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes - ATTAIN-2 - Eli Lilly and CompanySee more
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) - TRANSCEND-T2D-3 - Eli Lilly and CompanySee more
Obesity
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes - ATTAIN-2 - Eli Lilly and CompanySee more
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
Cardiovascular disease
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and CompanySee more
Elevated Lipoprotein A
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and CompanySee more
Heart failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
Hypertriglyceridemia
Study of Plozasiran in Adults With Severe Hypertriglyceridemia - SHASTA-4 - Arrowhead PharmaceuticalsSee more
Renal disease
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
